EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

Editorial: Toward Prognostic Precision in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms

Muhammer Ergenç iD, Hilmi Yazıcı iD

Cancer Control · 2026-06 · 33

DOI: 10.1177/10732748261476087 ↗

Kurz gefasst

Editorial in der Zeitschrift Cancer Control, online erschienen am 14.08.2026. Verfasst von Muhammer Ergenç und 1 weiteren Autor:innen. Beteiligte Einrichtung: Breast and Endocrine Surgery Unit, Department of General Surgery, Marmara University School of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pancreatic Neoplasms, Stomach Neoplasms, Intestinal Neoplasms. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), which encompass well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs), are a clinically and pathologically heterogeneous group of diseases with an increasing incidence, presenting significant challenges in diagnosis and treatment. This Special Collection brings together studies examining GEP-NEN management from four distinct perspectives: clinicopathological prognostic factors, sex-related survival differences, comparative real-world use and outcomes of long-acting somatostatin analogs, and tumor burden assessment using somatostatin receptor-based imaging. This editorial connects the studies in the collection, discussing the evolving field toward risk-adapted and personalized management of GEP-NENs, ie., a prognostic approach that integrates tumor biology with patient characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsPancreatic NeoplasmsStomach NeoplasmsIntestinal NeoplasmsPrecision MedicineHumansPrognosis

Stichwörter der Autor:innen

gastroenteropancreatic neuroendocrine neoplasmsprecision oncologyprognostic factorsrisk-adapted managementsomatostatin receptortumor heterogeneity

Autor:innen und Institutionen

  • Breast and Endocrine Surgery Unit, Department of General Surgery, Marmara University School of Medicine, Istanbul, Turkey.
  • Department of General Surgery, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.

ORCID-Profile: Muhammer Ergenç, Hilmi Yazıcı

Zitieren

APA

Ergenç, M., & Yazıcı, H. (2026). Editorial: Toward Prognostic Precision in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms. Cancer Control, 33. https://doi.org/10.1177/10732748261476087

Vancouver

Ergenç M, Yazıcı H. Editorial: Toward Prognostic Precision in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms. Cancer Control. 2026;33. doi:10.1177/10732748261476087

BibTeX
@article{Ergen2026,
  author = {Ergenç, Muhammer and Yazıcı, Hilmi},
  title = {Editorial: Toward Prognostic Precision in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms},
  journal = {Cancer Control},
  year = {2026},
  volume = {33},
  doi = {10.1177/10732748261476087}
}
Kostenlos starten →